Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038053
Filing Date
2019-08-07
Accepted
2019-08-07 08:31:57
Documents
81
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv525794_10q.htm 10-Q 850893
2 EXHIBIT 31.1 tv525794_ex31-1.htm EX-31.1 10352
3 EXHIBIT 31.2 tv525794_ex31-2.htm EX-31.2 10479
4 EXHIBIT 32.1 tv525794_ex32-1.htm EX-32.1 7981
  Complete submission text file 0001144204-19-038053.txt   8024133

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20190630.xml EX-101.INS 2381572
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20190630.xsd EX-101.SCH 59173
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20190630_cal.xml EX-101.CAL 70346
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20190630_def.xml EX-101.DEF 233470
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20190630_lab.xml EX-101.LAB 420822
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20190630_pre.xml EX-101.PRE 418674
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 191003953
SIC: 2834 Pharmaceutical Preparations